Journal
NEURON
Volume 101, Issue 5, Pages 863-+Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2019.01.002
Keywords
-
Categories
Funding
- NIH [R01GM100225, R01NS082271, R01NS107554, R21EY026363, 1UF1NS107710, R01DA35821, R01NS95809, R00MH103531]
- Deutsche Forschungsgemeinschaft [GO1011/12-1, SPP1926, CRC1080-B2]
- Brain Research Foundation
Ask authors/readers for more resources
Regulated secretion is critical for diverse biological processes ranging from immune and endocrine signaling to synaptic transmission. Botulinum and tetanus neurotoxins, which specifically proteolyze vesicle fusion proteins involved in regulated secretion, have been widely used as experimental tools to block these processes. Genetic expression of these toxins in the nervous system has been a powerful approach for disrupting neurotransmitter release within defined circuitry, but their current utility in the brain and elsewhere remains limited by lack of spatial and temporal control. Here we engineered botulinum neurotoxin B so that it can be activated with blue light. We demonstrate the utility of this approach for inducibly disrupting excitatory neuro-transmission, providing a first-in-class optogenetic tool for persistent, light-triggered synaptic inhibition. In addition to blocking neurotransmitter release, this approach will have broad utility for conditionally disrupting regulated secretion of diverse bioactive molecules, including neuropeptides, neuromodulators, hormones, and immune molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available